Bolorforosh Said 4
4 · HAEMONETICS CORP · Filed May 16, 2019
Insider Transaction Report
Form 4
Bolorforosh Said
EVP, Chief Technology Officer
Transactions
- Award
Non-qualified Stock Option (Right to Buy)
2019-05-14+4,451→ 4,451 totalExercise: $98.03Exp: 2026-05-14→ Common Stock (4,451 underlying) - Award
Common Stock
2019-05-14+1,275→ 2,210 total
Footnotes (4)
- [F1]The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2005 Long-Term Incentive Compensation Plan (as amended). The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant.
- [F2]Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.
- [F3]This number includes unvested RSUs previously reported.
- [F4]Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.